A carregar...
SpCas9-expression by tumor cells can cause T cell-dependent tumor rejection in immunocompetent mice
The CRISPR/Cas9 system has recently emerged as a highly efficient modality in genetic engineering and has been widely considered for various therapeutic applications. However, since the effector protein, SpCas9, has a bacterial origin, its immunogenicity must be explored in further depth. Here, we f...
Na minha lista:
| Publicado no: | Oncoimmunology |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Taylor & Francis
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6492962/ https://ncbi.nlm.nih.gov/pubmed/31069138 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2019.1577127 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|